Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALBOCICLIB Cause Liver function test increased? 188 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Liver function test increased have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.

188
Reports of Liver function test increased with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
15
Deaths
28
Hospitalizations

How Dangerous Is Liver function test increased From PALBOCICLIB?

Of the 188 reports, 15 (8.0%) resulted in death, 28 (14.9%) required hospitalization, and 3 (1.6%) were considered life-threatening.

Is Liver function test increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 188 reports have been filed with the FAERS database.

What Other Side Effects Does PALBOCICLIB Cause?

Fatigue (15,190) White blood cell count decreased (11,273) Neoplasm progression (10,885) Death (8,410) Nausea (8,189) Neutropenia (6,423) Alopecia (6,201) Diarrhoea (5,635) Asthenia (3,660) Off label use (3,405)

What Other Drugs Cause Liver function test increased?

METHOTREXATE (3,839) ADALIMUMAB (2,070) ETANERCEPT (1,829) LEFLUNOMIDE (1,521) ABATACEPT (1,415) TOCILIZUMAB (1,406) RITUXIMAB (1,325) SULFASALAZINE (1,263) HYDROXYCHLOROQUINE (1,259) TOFACITINIB (1,221)

Which PALBOCICLIB Alternatives Have Lower Liver function test increased Risk?

PALBOCICLIB vs PALIPERIDONE PALBOCICLIB vs PALIVIZUMAB PALBOCICLIB vs PALONOSETRON PALBOCICLIB vs PAMIDRONATE PALBOCICLIB vs PAMIDRONIC ACID

Related Pages

PALBOCICLIB Full Profile All Liver function test increased Reports All Drugs Causing Liver function test increased PALBOCICLIB Demographics